Journey Medical (NasdaqCM:DERM) Q3 2026 Earnings call November 12, 2026 04:30 PM ET Company ParticipantsJaclyn Jaffe - Senior Director of Corporate OperationsClaude Maraoui - Co-Founder, President, and CEOJoseph Benesch - CFORamsey Alloush - COO and General CounselConference Call ParticipantsBrandon Folkes - AnalystScott Henry - AnalystWesley Villegas - AnalystAmine Chaherli - AnalystOperatorLadies and gentlemen, thank you for standing by. Good afternoon and welcome to Journey Medical's third quarter 2026 f ...